The report ?Global Proton Therapy Market Outlook 2021? provides an in-depth analysis of global proton therapy treatment market with focus on major regional market such as North America, Europe and Asia Pacific. North America is the world?s largest proton therapy market with high predominance in the US. In Europe, Germany and the UK are major markets. The proton therapy systems market has been segmented into pencil beam scanning systems, uniform scanning systems and passive scattering systems on the basis of type of system. Out of these, pencil beam scanning being most precise form of proton therapy enjoys highest popularity.
Growth of the global proton therapy industry is driven by rise in cancer incidences, especially prostate cancer. Rising prevalence of chronic diseases in ageing population globally; and minimal invasiveness associated with use of proton therapy. However, major industry restraints include stringent regulations, high installation costs and reimbursement being limited to few uncommon cancer types. Global proton therapy industry is highly consolidated with three major players - IBA Proton Therapy Inc, Varian Medical Systems and Hitachi Limited dominating the market. These players have been profiled in the report.
Market Segmentation by Region
? North America
? The US
? Asia Pacific
? Europe
Key Vendors
? IBA Proton Therapy Inc
? Varian Medical Systems
? Hitachi Ltd

Proton beam therapy or proton therapy, part of particle therapy is the most advanced form of radiation therapy with capability to precisely localize radiation dosage. It is an external beam radiotherapy which makes use of focused ionizing radiation. It is highly advantageous as it successfully eradicates side-effects associated with other forms of conventional radiation therapies for destroying cancer cells. This therapy finds highest use in treatment of cancers of the central nervous system and brain, head and neck cancers, prostate cancer, breast cancer, lung cancer, gastrointestinal and liver cancer, ocular cancer and others.
The proton therapy systems market has been segmented into pencil beam scanning systems, uniform scanning systems and passive scattering systems on the basis of type of system. Out of these, pencil beam scanning being most precise form of proton therapy enjoys highest popularity.
Proton therapy is widely accepted world over due to its non-invasive and target-specific nature, causing minimal damage to healthy tissues. Growth of the industry is highly driven by rise in cancer incidences, especially prostate cancer. Rising prevalence of chronic diseases in ageing population globally; and minimal invasiveness associated with use of proton therapy. However, major industry restraints include stringent regulations, high installation costs and reimbursement being limited to few uncommon cancer types.
In the report, proton therapy market assessment is done across major markets such as North America, Asia Pacific and Europe. North America is the world?s largest proton therapy market with high predominance in the US. In Europe, Germany and the UK are major markets; whereas Asia Pacific region features Japan and China as its major destination for proton therapy. In-depth analysis of proton therapy market in aforementioned regions is done on the basis of installed base, proton therapy facilities (operational and upcoming) as well as patient treatment volume in respective markets.
Global proton therapy industry is highly consolidated with three major players - IBA Proton Therapy Inc, Varian Medical Systems and Hitachi Limited dominating the market. These industry players are profiled herein based on attributes such as business overview, product segments, financial and business strategies. The report also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global proton therapy market.